Internal Medicine, Infectious Disease · Laguna Beach, CA
NPI
1083610703
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
31852 Coast Hwy, Ste 201
Laguna Beach, CA, 92651
Phone (949) 715-0505
Groups this clinician bills Medicare through
Medicare paid, 2024
$607K
7,983 services
Medicare patients, 2024
1,076
Average age 79
Drug cost, 2024
$352K
993 prescriptions
Company payments, 2025
$11K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jagadeesh C Reddy was code 99232 (hospital e&m - subsequent), 6,400 times for 1,009 patients. In total Jagadeesh C Reddy billed 7,983 services in 9 codes, and Medicare paid $607K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 6,400 | 1,009 | $69.08 | $442K |
| 99222 Hospital E&M - Initial | Facility | 1,305 | 1,050 | $113.47 | $148K |
| 99231 Hospital E&M - Subsequent | Facility | 137 | 43 | $43.32 | $5,934 |
| 99213 Office E&M - Established | Office | 118 | 55 | $81.76 | $9,648 |
By year: 2022 $428K for 5,873 services; 2023 $529K for 7,141 services; 2024 $607K for 7,983 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jagadeesh C Reddy prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 299 prescriptions and refills. In total Jagadeesh C Reddy wrote 993 Medicare prescriptions that cost $352K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 299 | 299 | 87 | $52K |
| Daptomycin Generic | 205 | 205 | 66 | $122K |
| Ertapenem Ertapenem Sodium | 150 | 150 | 71 | $65K |
| Cefepime Hcl Generic | 62 | 62 | 23 | $15K |
| Sodium Chloride 0.9 % Sodium Chloride | 46 | 46 | 18 | $1,422 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 37 | 37 | 12 | $7,750 |
| Meropenem Generic | 21 | 21 | Under 11 | $1,927 |
| Doxycycline Hyclate Generic | 19 | 20 | Under 11 | $243 |
| Levofloxacin Generic | 17 | 17 | Under 11 | $41.09 |
| Micafungin Micafungin Sodium | 16 | 16 | Under 11 | $6,396 |
| Cefuroxime Cefuroxime Axetil | 14 | 14 | Under 11 | $1,025 |
| Adrenalin Epinephrine | 13 | 13 | 12 | $198 |
| Diphenhydramine Hcl Generic | 12 | 12 | 12 | $33.75 |
| Zerbaxa Ceftolozane/Tazobactam | 11 | 11 | Under 11 | $33K |
Brand drugs: 103 claims; generic drugs: 890 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jagadeesh C Reddy $11K ($11K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $6,058.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.